Trial
NCT01215981
Influenza Vaccine Post Allogeneic Transplant
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Hematopoietic Stem Cell Transplant
Intervention
Influenza vaccine
Why stopped
Lack of patients and no longer influenza vaccine season.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28